Info of Live Biotherapeutic Products

The Therapeutic Potential of Eubacterium hallii in Diabetes Management Eubacterium hallii Diabetes

The Role of Ruminococcus gnavus in Crohn's Disease Ruminococcus gnavus Crohn's Disease

Parabacteroides goldsteinii in Obesity Control Strategies Parabacteroides goldsteinii Obesity

Oxalobacter formigenes in Kidney Stone Prevention Oxalobacter formigenes Kidney Stone

Butyricicoccus pullicaecorum in CRC Prevention and Therapy Butyricicoccus pullicaecorum CRC

B. vulgatus and B. dorei Inhibit Atherosclerosis B. vulgatus B. dorei Atherosclerosis

Anticancer Potential of Probiotic Enterococcus lactis IW5 Anticancer Enterococcus lactis IW5

Harnessing Lactococcus lactis for Breakthroughs in Immunotherapy Lactococcus lactis Immunotherapy

Christensenella minuta in Obesity and Metabolic Health Christensenella minuta Metabolic disease

Bacteroides thetaiotaomicron Against CDI Bacteroides thetaiotaomicron CDI

Two Probiotics Combined Offers New Hypertension Therapy Probiotics Hypertension

Probiotic Treatment in Improving Major Depressive Disorder Probiotic Depressive Disorder

Enhancing Solid Tumor Targeting with Probiotic-Guided CAR-T Cells Probiotic CAR-T Cell Therapy

The Potential of Probiotics for Treating Foodborne Diseases Diarrhea

Research and Development Status of Single-Strain LBPs Single-Strain

Engineered LBP for the Treatment of Bacterial Infection Engineered Bacteria Infection

Overcoming Physiological Challenges in LBP Discovery Genomics

The Potential of Probiotics in Neurodevelopmental Disorders Neurodevelopmental Diseases

Research and Development Status of Multi-Strain LBPs Multi-Strain

Engineered LBP for the Treatment of IBD IBD

Discovery and Development Process of Live Biotherapeutics Services

Overcoming Physiological Challenges in LBP Delivery Delivery

Overview of Live Biotherapeutic Products Types of LBP

Challenges and Opportunities in Live Biotherapeutic Products Development LBP

Harnessing Probiotic-Derived Extracellular Vesicles (pEVs): Pioneering Next-Generation Postbiotic Solutions for Rheumatoid Arthritis Therapy pEVs Rheumatoid Arthritis

LBP Development Gut Position Statement & Expert CRO Solutions

Living Hydrogel Development: CRO Services for Microorganism-Material Synergy

Next-Gen Probiotic CRO Services | Novel Strain Isolation & Analysis

Adjunctive Periodontitis Therapy: LBP & Probiotic Development Services

Akkermansia muciniphila & FXR/XBP1u Signaling: CRO Services for Colitis LBP Development

Melatonin & Akkermansia muciniphila in MASLD Fibrosis: Multi-Omic Research & CRO Services

Gut Microbiome in Colorectal Cancer

Oncolytic Probiotics CRO Services | Molecular Pili & Solid Tumor Therapy

SCFA & HSCT Research Services | Gut-Immune Axis CRO Solutions

Metabolic Control of Clostridioides difficile Virulence Leveraging Synthetic Consortia and Genetic Engineering for LBP Development

Probiotic Peptidoglycan Mechanisms & LBP Development Services

Probiotic Synergy & Metabolomics Study

A. muciniphila Protein Research

C. butyricum & Mucosal Immunity

Periodontal Disease: Antibiotics to LBPs

Skin Microbiome & AD Research

Diarrheal Microbiome Metagenomics

Canine Microbiome Probiotic Translation Study & CRO Solutions

Lactiplantibacillus pentosus Genomic Analysis & LBP Services

Peptide-Based Antimicrobials

Gut Microbiota & Bile Acid Profiling in IBD

Synbiotic Development: E. hirae & Oligosaccharides

Feline Probiotic Development & Genomic Characterization

Probiotic Genomic & Functional Analysis in Colitis

Cobalamin & Faecalibacterium duncaniae Research Solutions

Akkermansia muciniphila & Inflammatory Disease Solutions

Akkermansia muciniphila LBP Solutions

Anaerobutyricum Research & CRO Solutions

Insights into Gut Microbiome Research & LBP Development Solutions